Loading
Yanuki
ARTICLE DETAIL
Nike Stock: Investor Activity and Analyst Ratings in Q4 2025 | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Nike Stock: Investor Activity and Analyst Ratings in Q4 2025 | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026

Finance / Stock Market

Nike Stock: Investor Activity and Analyst Ratings in Q4 2025

This article summarizes recent institutional investor activity and analyst ratings for Nike (NKE) stock during the fourth quarter of 2025. Several firms adjusted their positions, and analysts have updated their price targets and ratings. Un...

Fiduciary Trust Co Trims Holdings in NIKE, Inc. (NYSE:NKE)
Share
X LinkedIn

nike stock
Nike Stock: Investor Activity and Analyst Ratings in Q4 2025 Image via MarketBeat

Key Insights

  • **Institutional Investor Activity:** Several institutional investors, including Fiduciary Trust Co, DZ BANK AG, and Cetera Investment Advisers, adjusted their holdings in NIKE during Q4 2025. Some reduced their positions, while others increased their stakes.
  • **Analyst Ratings:** Analysts have mixed opinions on NIKE, with a consensus rating of "Moderate Buy" and an average price target of $80.48. Recent reports show analysts adjusting price targets and ratings, reflecting varying perspectives on the stock's value.
  • **Insider Transactions:** Both buying and selling activity occurred among Nike insiders. Director Robert Holmes Swan increased his holdings, while Chairman Mark G. Parker decreased his position.

In-Depth Analysis

## Background

Institutional investor activity can significantly influence stock prices. Monitoring these movements provides valuable insights into market sentiment. Similarly, analyst ratings and price targets offer perspectives on a stock's potential value, though these are not always definitive.

## Institutional Investor Activity

  • **Fiduciary Trust Co:** Reduced its holdings by 15.3%, owning 100,612 shares worth $7,613,000.
  • **DZ BANK AG:** Decreased its stake by 19.9%, holding 321,499 shares valued at $24,328,000.
  • **Cetera Investment Advisers:** Cut its holdings by 14.6%, owning 195,444 shares worth $14,789,000.
  • **Other Notable Changes:**
  • Norges Bank initiated a new position valued at $1,126,288,000.
  • Wellington Management Group LLP increased its holdings by 32.4%.
  • Renaissance Technologies LLC boosted its stake by 1,302.7%.

These changes reflect varied strategies among institutional investors, possibly influenced by Nike's earnings reports and broader market conditions.

## Analyst Ratings and Price Targets

Recent analyst actions include:

  • **BMO Capital Markets:** Reduced the price target from $95.00 to $92.00, maintaining an "outperform" rating.
  • **Jefferies Financial Group:** Upgraded the rating from "hold" to "buy," increasing the price target from $75.00 to $115.00.
  • **Stifel Nicolaus:** Lowered the price target from $75.00 to $64.00, keeping a "hold" rating.
  • **JPMorgan Chase & Co.:** Cut the price objective from $64.00 to $56.00, maintaining a "neutral" rating.
  • **Needham & Company LLC:** Reduced the target price from $84.00 to $80.00, affirming a "buy" rating.

The consensus among analysts is a "Moderate Buy," with an average price target of $80.48. These ratings and targets suggest cautious optimism about Nike's future performance.

## Insider Transactions

  • **Robert Holmes Swan (Director):** Bought 8,600 shares at an average price of $58.46, totaling $502,756.00.
  • **Mark G. Parker (Chairman):** Sold 169,732 shares at an average price of $72.83, totaling $12,361,581.56.

Insider transactions can provide insights, but they should be considered alongside other factors. A director buying shares may indicate confidence, while a chairman selling shares may be due to various personal financial reasons.

Read source article

FAQ

- **Q: What is the current consensus rating for Nike stock?

- **Q: What is the average price target for Nike stock?

- **Q: Who are some of the institutional investors that have recently adjusted their positions in Nike?

Takeaways

  • Monitor institutional investor activity to gauge market sentiment.
  • Consider analyst ratings and price targets as part of a broader analysis.
  • Be aware of insider transactions, but don't rely solely on them for investment decisions.
  • Stay informed about Nike's earnings reports and overall financial health.

Discussion

Do you think these investor activities and analyst ratings accurately reflect Nike's future potential? Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.